Interestingly, in a series of 110 psoriasis patients treated with anti-TNF therapy, the majority of non-responders were smokers, especially those with overweight/obesity or higher baseline PASI scores (35). This evidence concerns the gene TNF and obesity due to melanocortin 4 receptor deficiency.